Drug Wars: The Battle to Put a Lid on Rising Prices
In the first of five stories on the battle to address skyrocketing drug prices in the U.S., Institutional Investor looks at how the actions of Turing Pharmaceuticals CEO Martin Shkreli set off a firestorm in Washington.
Khadijah M Silver
November 25, 2015